Treatment of Immune Thrombocytopenia in Adults: The Role of Thrombopoietin-Receptor Agonists
- 1 January 2015
- journal article
- review article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 52 (1), 16-24
- https://doi.org/10.1053/j.seminhematol.2014.10.006
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet productionBritish Journal of Haematology, 2009
- Epidemiology of immune thrombocytopenic purpura in the General Practice Research DatabaseBritish Journal of Haematology, 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttalJournal of Thrombosis and Haemostasis, 2008
- The Pathophysiology of ITP Revisited: Ineffective Thrombopoiesis and the Emerging Role of Thrombopoietin Receptor Agonists in the Management of Chronic Immune Thrombocytopenic PurpuraHematology-American Society Hematology Education Program, 2008
- Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and managementThrombosis and Haemostasis, 2008
- Prevalence of immune thrombocytopenia: analyses of administrative dataJournal of Thrombosis and Haemostasis, 2006
- Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patientsBritish Journal of Haematology, 2003
- The Incidence of Idiopathic Thrombocytopenic Purpura in Adults Increases With AgeBlood, 1999
- Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.JCI Insight, 1987